AVEO Oncology
AVEO
#7099
Rank
S$0.67 B
Marketcap
S$19.44
Share price
0.00%
Change (1 day)
162.13%
Change (1 year)

AVEO Oncology (AVEO) - Total debt

Total debt on the balance sheet as of September 2022 : S$50.12 Million

According to AVEO Oncology 's latest financial reports the company's total debt is S$50.12 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

AVEO Oncology - Total debt on balance sheet (from 2008 to 2022)

Total debt by year

Year Total debt Change
2021-12-31S$51.33 M168.03%
2020-12-31S$19.15 M-9.89%
2019-12-31S$21.25 M-18.25%
2018-12-31S$26 M5.22%
2017-12-31S$24.71 M21.94%
2016-12-31S$20.26 M51.28%
2015-12-31S$13.39 M-50.91%
2014-12-31S$27.28 M12.15%
2013-12-31S$24.33 M-23.58%
2012-12-31S$31.84 M1.72%
2011-12-31S$31.3 M3.84%
2010-12-31S$30.14 M8.75%
2009-12-31S$27.71 M-7.94%
2008-12-31S$30.11 M38.78%
2007-12-31S$21.69 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Biogen
BIIB
S$8.54 B 16,937.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$3.50 B 6,894.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
S$21.51 M-57.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$66.14 B 131,857.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$55.08 B 109,792.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$70.73 B 141,024.61%๐Ÿ‡บ๐Ÿ‡ธ USA